Share

Search your stocks

Ctrl+K

AMBEYAmbey Laboratories Ltd.

42.95(+1.06%)

1W: +3.03%

1M: +7.05%

1Y: -

Ambey Laboratories Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong demand for products, building on a consistent upward trend from previous quarters.
Operating margin improved to 20% due to effective cost management, showing a positive shift from last year’s 15%.
Net profit margin increased to 12%, reflecting enhanced operational efficiency and a robust pricing strategy compared to earlier quarters.

NEGATIVES

Raw material costs surged by 10% in the last quarter, impacting profitability despite increased sales.
Cash flow from operations decreased by 5%, raising concerns about liquidity management versus previous quarters.
High debt levels remain a challenge, with interest coverage declining, putting pressure on future financial flexibility.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-